Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Neurologia ; 30(2): 77-82, 2015 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-24837525

ABSTRACT

INTRODUCTION: Early-onset dementia (EOD) is defined as dementia with onset before the age of 65 years. EOD is increasingly recognised as an important clinical and social problem with devastating consequences for patients and caregivers. OBJECTIVE: Determine the annual crude incidence rate and the specific incidence rates by sex and age in patients with EOD, and the standardised rate using the last national census of the population of Argentina (NCPA), from 2010. MATERIALS AND METHODS: Hospital Privado de Comunidad, Mar del Plata, Argentina, attends a closed population and is the sole healthcare provider for 17 614 people. Using the database pertaining to the Geriatric Care department, we identified all patients diagnosed with EOD between 1 January, 2005 and 31 December, 2011. EOD was defined as dementia diagnosed in patients younger than 65. RESULTS: The study period yielded 14 patients diagnosed with EOD out of a total of 287 patients evaluated for memory concerns. The crude annual incidence of EOD was 11 per 100 000/year (CI 95%: 6.25-19.1): 17 per 100 000 (CI 95%: 7.2-33.1) in men and 8 per 100 000 (CI 95%: 3.4-17.2) in women. We observed a statistically significant increase when comparing incidence rates between patients aged 21 to <55 years and ≥ 55 to <65 years (3 vs 22 per 100 000, P=.0014). The rate adjusted by NCPA census data was 5.8 cases of EOD habitants/year. CONCLUSION: This study, conducted in a closed population, yielded an EOD incidence rate of 11 per 100 000 inhabitants/year. To the best of our knowledge, this is the first prospective epidemiological study in Argentina and in Latin America.


Subject(s)
Dementia/epidemiology , Adult , Age of Onset , Aged , Aged, 80 and over , Argentina/epidemiology , Dementia/diagnosis , Female , Humans , Incidence , Male , Middle Aged , Prospective Studies , Young Adult
2.
Epilepsy Behav ; 27(1): 29-35, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23369763

ABSTRACT

INTRODUCTION: The annual incidence of seizure disorders rises sharply after the age of 60. Treatment is complicated by the normal physiological changes of aging, comorbid diseases, and polypharmacy. Despite this, approximately 80% of the patients become seizure-free. OBJECTIVES: The objectives of this study were to (1) analyze the outcome of a cohort of patients with newly-diagnosed epilepsy over the age of 65, (2) describe epilepsy etiology and seizure type, and (3) classify the outcome according to the latest ILAE classification proposal for drug-resistant epilepsy (2010). METHODS: All patients with newly-diagnosed epilepsy over the age of 65 who were evaluated in two different institutions were included. Seizures and epilepsy syndromes were classified according to the International League Against Epilepsy proposal (2010). Epilepsy outcomes were also analyzed according to the proposal of the ILAE Commission on Therapeutic Strategies (2010). RESULTS: One hundred and twenty-two patients were included with a median follow-up time of 15 months. Median age of diagnosis was 78 years. Seventy-seven patients (55%) had epilepsy of unknown cause, and 55 (45%) had structural-metabolic epilepsy. The proportions of seizure-free patients at 6, 12, 18, and 24 months were 90%, 77%, 74%, and 67%, respectively. Thirty percent of patients experienced adverse effects (AEs). We found a statistically significant trend toward a higher frequency of AEs as the number of concomitant medications rose and in younger patients. According to the 2010 ILAE classification proposal for drug-resistant epilepsy criteria, 55.8% of the patients were seizure-free, 12.3% had treatment failure, and 32% had undetermined seizure outcome. CONCLUSION: Patients with newly-diagnosed epilepsy after the age of 65 have very good chances of achieving seizure control with AED treatment. It seems that fulfilling the ILAE classification proposal for drug-resistant epilepsy (2010) criteria for seizure freedom was more difficult in our cohort. Older patients also seem to be more prone to suffering from AEs.


Subject(s)
Aging/pathology , Epilepsy/diagnosis , Outcome Assessment, Health Care , Age Factors , Aged , Aged, 80 and over , Cohort Studies , Epilepsy/classification , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Retrospective Studies , Statistics, Nonparametric , Time Factors
3.
Science ; 338(6108): 773-5, 2012 Nov 09.
Article in English | MEDLINE | ID: mdl-23139326

ABSTRACT

Stars are generally spherical, yet their gaseous envelopes often appear nonspherical when ejected near the end of their lives. This quirk is most notable during the planetary nebula phase, when these envelopes become ionized. Interactions among stars in a binary system are suspected to cause the asymmetry. In particular, a precessing accretion disk around a companion is believed to launch point-symmetric jets, as seen in the prototype Fleming 1. Our finding of a post-common-envelope binary nucleus in Fleming 1 confirms that this scenario is highly favorable. Similar binary interactions are therefore likely to explain these kinds of outflows in a large variety of systems.

4.
Neurologia ; 27(1): 22-7, 2012 Jan.
Article in Spanish | MEDLINE | ID: mdl-21764483

ABSTRACT

INTRODUCTION: Chronic subdural hematoma in adults (CSDH) has a global crude incidence of 14.1/100,000 per year in our institution captive population. There is no single treatment protocol. In our hospital we choose a minimal invasive technique (trans-marrow puncture) without general anaesthesia due to the age of the population. A descriptive study of patients with CSDH and treatment results, including a laterality analysis, is presented. MATERIAL AND METHODS: We retrospectively searched patients with (CSDH) between January 1998 and May 2009. The diagnosis was made by neuroimaging techniques in all patients. The preferred treatment was trans-marrow puncture; exceptionally some patients were treated by burr holes or craniotomy. RESULTS: We found 127 patients. Age, gender, midline displacement, hospitalisation days, and number of procedures, were not a predictive factor of mortality in the first month. A slight majority (55%) of CSDH were on the left side, with no statistically significant difference. There were 6 (4.7%) deaths during hospitalisation. In our series cumulative mortality at six months was 11.8%. Markwalder scale at admission was not a predictive factor of statistically significant mortality. An 80% of the patients received trans-marrow puncture as single procedure was performed on 80% of the patients. CONCLUSIONS: The results of our study suggest that trans-marrow puncture is an acceptable procedure, with low mortality, and less hospitalisation days and complications. Mortality, associated mechanisms, age, gender, midline displacement are no different than in others previous publications. We found a higher frequency of hematomas to the left, as in other series. Meta-analysis studied need to be performed to determine more accurately the frequency of this dominance.


Subject(s)
Hematoma, Subdural, Chronic/surgery , Minimally Invasive Surgical Procedures/methods , Neurosurgical Procedures/methods , Age Factors , Aged , Aged, 80 and over , Craniotomy , Databases, Factual , Female , Functional Laterality , Hematoma, Subdural, Chronic/physiopathology , Hospital Mortality , Humans , Male , Middle Aged , Neurosurgical Procedures/mortality , Predictive Value of Tests , Risk Factors , Sex Factors , Tomography, X-Ray Computed , Treatment Outcome
5.
Neurologia ; 26(9): 528-32, 2011 Nov.
Article in Spanish | MEDLINE | ID: mdl-21414691

ABSTRACT

BACKGROUND: Oral anticoagulant therapy (ACO) is considered an independent predictor of mortality in patients with intracerebral haemorrhage (ICH), with the role of the international normalised ratio (INR) being unclear. The aim of this work is to evaluate the relationship between ACO and the INR value and the ICH volume, and to determine the relationship between both variables and mortality. PATIENTS AND METHODS: Patients were retrospectively analysed using the Private Community Cerebrovascular Hospital Register (Registro Cerebrovascular del Hospital Privado de Comunidad), between December 2003 and May 2009. Volumes of the haematomas (dependent variable) were calculated from the first image performed, using the abc/2 method. Independent variables were age, gender, vascular risk factors, site of bleeding, intraventricular dump, clinical severity (Glasgow scale), time to image, antiplatelet drugs, and INR value on admission. An analysis of the relationship between all these variables and mortality was also performed. RESULTS: A total of 327 patients with HIC were identified (35 with ACO). Median volume was higher in the anticoagulated patients (55ml vs 24ml P<.05), with no statistically significant relationship between volume and the other variables. In the multivariate analysis, a statistically significant higher mortality associated to volume was observed, but not with anticoagulation. CONCLUSIONS: Oral anticoagulation was associated with a higher initial volume of the haematoma, with no correlation between the INR value and volume. The HIC volume was directly related to mortality, however, like the volume, the INR was not associated with increased mortality.


Subject(s)
Anticoagulants/therapeutic use , Cerebral Hemorrhage/drug therapy , Cerebral Hemorrhage/mortality , International Normalized Ratio , Aged , Aged, 80 and over , Cerebral Hemorrhage/diagnosis , Cerebral Hemorrhage/pathology , Female , Hematoma/drug therapy , Hematoma/mortality , Hematoma/pathology , Humans , Male , Prognosis , Registries , Retrospective Studies
13.
Am J Physiol ; 269(1 Pt 2): F110-5, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7631824

ABSTRACT

To test the hypothesis that angiotensin II (ANG II) is necessary for normal embryonic and postnatal kidney development, the effect of angiotensin receptor blockade or angiotensin converting enzyme inhibition on nephrovascular development was studied in newborn Sprague-Dawley rats and in Rana catesbeiana tadpoles undergoing prometamorphosis. Blockade of ANG II type 1 receptor (AT1) in newborn rats induced an arrest in nephrovascular maturation and renal growth, resulting in altered kidney architecture, characterized by fewer, thicker, and shorter afferent arterioles, reduced glomerular size and number, and tubular dilatation. Inhibition of ANG II generation in tadpoles induced even more marked developmental renal abnormalities. Blockade of ANG II type 2 receptor (AT2) in newborn rats did not alter renal growth or morphology. Results indicate that ANG II regulates nephrovascular development, a role that is conserved across species.


Subject(s)
Angiotensin II/pharmacology , Kidney/embryology , Kidney/growth & development , Nephrons/embryology , Nephrons/growth & development , Angiotensin Receptor Antagonists , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Animals, Newborn , Blood Vessels/drug effects , Blood Vessels/embryology , Blood Vessels/growth & development , Enalapril/pharmacology , Larva , Nephrons/drug effects , Rana catesbeiana/growth & development , Rats , Rats, Sprague-Dawley , Renal Circulation/drug effects , Renal Circulation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...